Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog
DRUG MONITORING, BENZODIAZEPINES, QUANTITATIVE, URINE |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB1252 Geisinger Epic ID: 52933 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Random urine | |
Preferred collection container: |
||
Alternate Collection Container: |
Sterile specimen container
|
|
Specimen required: |
20 mL random urine; minimum 5 mL. | |
SPECIMEN PROCESSING |
||
Transport temperature: |
Room temperature. | |
Specimen stability: |
Room temperature: 14 days. Refrigerated: 14 days. Frozen: 30 days. | |
Rejection criteria: |
Preserved samples. | |
TEST DETAILS |
||
CPT code(s): |
80346 | |
Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam | |
Methodology: |
Mass Spectrometry |
|
Synonyms: |
Quest test code 16914, DM Benzo, Prescription Drug Monitoring, Pain Management
|
|
Clinical significance: |
This test measures levels of benzodiazepine metabolites in urine. Benzodiazepine metabolites are biomarkers for monitoring possible use or non-use of benzodiazepine drugs. The test is a definitive drug assay using the liquid chromatography/mass spectrometry (LC/MS-MS) method of analysis. |